PMI
Picard Medical, Inc.
Next earnings ≈ Aug 14, 2026 · est. from filing cadence
Last earnings -8.4% on 2026-05-21
$0.14
▼ -10.93%$0.14▼ -96.89%
over 1Y
L $0.14EODHDH $13.20
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-10.9%
1W-28.7%
1M+1.9%
3M-84.5%
YTD-92.2%
1Y-96.9%
Avoid
Conviction
Horizon
Medium (3–12mo)
Revenue grew 12.5% YoY; but unprofitable (net margin -546.6%).
Revenue (FY2025) $4.94M · FY2025
Picard Medical, Inc. shows $4.94M in FY2025 revenue (+12.5% YoY), a -546.6% net margin, and -712.6% ROE.
Financials · annual, by fiscal year
| Line item | FY24 | FY25 |
|---|---|---|
| Revenue | $4.39M | $4.94M |
| Gross profit | -$112K | -$204K |
| Operating income | -$13.7M | -$13.3M |
| Net income | -$21.1M | -$27.0M |
| Diluted EPS | — | — |
| Net margin | -479.5% | -546.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$3.27M
EV / EBITDA—
EV / Sales0.7
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-251.9%
FCF yield—
Quality & risk
ROIC (est.)-276.4%
Free cash flow—
Total debt—
Net cash$7.45M
Altman Z-Score-6.04 distress
Piotroski F-Score3/7
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — delisting notice (2026-05-21). Worth a closer look.
- 8-K Officer / director change2026-06-24
- 8-K Officer / director change2026-06-02
- 8-K Reg FD disclosure2026-05-29
- 8-K Delisting notice2026-05-21
- S-1 Securities registration2026-05-20
- 10-Q Quarterly report2026-05-15
- 10-K/A Restated periodic report2026-05-15
- 8-K Delisting notice2026-05-11
- 8-K Material agreement2026-05-05
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-182026-06-24open ↗PRE 14APeriod ending 2026-07-172026-06-15open ↗SCHEDULE 13G/AFiling2026-06-05open ↗144Filing2026-06-03open ↗8-KPeriod ending 2026-06-012026-06-02open ↗144Filing2026-06-01open ↗424B3Filing2026-06-01open ↗EFFECTFiling2026-05-29open ↗8-KPeriod ending 2026-05-292026-05-29open ↗8-KPeriod ending 2026-05-152026-05-21open ↗S-1Filing2026-05-20open ↗10-QPeriod ending 2026-03-312026-05-15open ↗
Frequently asked
- Is Picard Medical, Inc. (PMI) a buy?
- PMI currently carries a Avoid rating with 3/5 conviction, derived from its latest SEC filings. Revenue grew 12.5% YoY; but unprofitable (net margin -546.6%).
- What is Picard Medical, Inc.'s quality score?
- PMI scores 44.56862745098039/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0002030617, latest 10-Q filed 2026-05-15) · EODHD · as of 6/23/2026, 12:12:35 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.